Form 4: Oracle CEO Sells 10,000 Shares Under 10b5-1 Plan

Oracle's Chief Executive Officer, Clayton M. Magouyrk, sold 10,000 shares of common stock for approximately $1.92 million under a pre-arranged trading plan.

Summary

• Clayton M. Magouyrk, Oracle's Chief Executive Officer, disposed of 10,000 shares of Oracle Common Stock.
• The transaction occurred on December 19, 2025.
• The shares were sold at a weighted average price of $192.5152 per share.
• The total value of the transaction was approximately $1,925,152.
• Following this transaction, Magouyrk beneficially owns 144,030 shares of Oracle Common Stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 4

Explanation: The CEO's sale of 10,000 shares, while executed under a Rule 10b5-1 plan, could be interpreted by some investors as a neutral to slightly negative signal regarding the stock's near-term prospects or valuation. However, 10b5-1 plans are pre-scheduled and often for personal financial planning, reducing the immediate negative implication.

Negatives

• A sale of 10,000 shares by the Chief Executive Officer could be interpreted by some investors as a signal of reduced confidence or that the stock is fully valued, despite being executed under a Rule 10b5-1 plan.

Stakeholder Impact

• Shareholders may interpret the CEO's sale of shares as a signal, potentially influencing their perception of the company's stock value or future prospects.

Key Dates

Recommendation

The sale of 10,000 shares by the CEO, while notable, was executed under a pre-arranged Rule 10b5-1 plan, which suggests it's part of a personal financial strategy rather than a reaction to new, undisclosed negative information. Without additional context on the company's fundamentals, future outlook, or broader market conditions, this single transaction does not provide sufficient grounds for a strong change in investment thesis. Investors should monitor future insider activity and company performance.

Keywords

Oracle, ORCL, insider trading, stock sale, CEO, Clayton M. Magouyrk, Form 4, common stock, 10b5-1 plan